The Journal of Pain
Volume 10, Issue 9 , Pages 969-975 , September 2009

DRD3 Ser9Gly Polymorphism Is Related to Thermal Pain Perception and Modulation in Chronic Widespread Pain Patients and Healthy Controls

  • Stéphane Potvin

      Affiliations

    • Service of Neurosurgery, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Canada
    • ,
  • Annie Larouche

      Affiliations

    • Departments of Psychiatry and Physiology, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Canada
    • ,
  • Edith Normand

      Affiliations

    • Service of Neurosurgery, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Canada
    • ,
  • Juliana Barcellos de Souza

      Affiliations

    • Service of Neurosurgery, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Canada
    • ,
  • Isabelle Gaumond

      Affiliations

    • Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, Quebec, Canada
    • ,
  • Sylvain Grignon

      Affiliations

    • Departments of Psychiatry and Physiology, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Canada
    • ,
  • Serge Marchand

      Affiliations

    • Service of Neurosurgery, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Canada
    • Corresponding Author InformationAddress reprint requests to Dr Serge Marchand, University of Sherbrooke, Faculty of Medicine, Axe Douleur CRC-CHUS, 3001, 12e Avenue Nord, Sherbrooke, Canada, J1H 5N4.

Received 14 August 2008 ,Revised 19 January 2009 ,Accepted 18 March 2009.

References 

  1. Altier N, Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 1999;65:2269–2287
  2. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): A review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23:S145–S162
  3. Dalal S, Melzak R. Potentiation of opioid analgesia by psychostimulant drugs: A review. J Pain Sympt Manage. 1998;16:245–253
  4. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain. 2006;125:216–224
  5. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Gen. 2005;14:135–143
  6. Fathalli F, Rouleau GA, Xiong L, Tabbane K, Benkelfat C, Deguzman R, et al. No association between the DRD3 Ser9Gly polymorphism and schizophrenia. Schizophr Res. 2008;98:98–104
  7. Garcia-Fructuoso FJ, Lao-Villadoniga JI, Beyer K, Santos C. Relationship between catechol-O-methyltransferase genotypes and fibromyalgia's severity. Rheumatol Clin. 2006;2:168–172
  8. Gardner EL. Brain reward mechanisms. In:  Lowinson JH,  Ruiz P,  Millman RB,  Langrod JG editor. Substance Abuse: A Comprehensive Textbook. Baltimore: Williams & Wilkins; 1997;p. 51–87
  9. Gürsoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int. 2003;23:104–107
  10. Hagelberg N, Martikainen IK, Mansikka H, Hinkka S, Nagren K, Hietala J, et al. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain. 2002;99:273–279
  11. Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 2005;52:2495–2505
  12. Jaaskelainen SK, Rinne JO, Forssell H, Tenovuo O, Kaasinen V, Sonninen P, et al. Role of the dopaminergic system in chronic pain: A fluorodopa-PET study. Pain. 2001;90:257–260
  13. Jeanneteau F, Funalot B, Jankovic J, Deng H, Lagarde JP, Lucotte G, et al. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci U S A. 2006;103:10753–10758
  14. Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005;114:295–302
  15. Kim H, Mittal DP, Iadarola MJ, Dionne RA. Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J Med Genet. 2006;43:e40
  16. Kim H, Neubert JK, Miguel AS, Krishnaraju RK, Idarola MJ, Goldman MJ, et al. Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain. 2004;109:488–496
  17. Kunugi H, Vallada HP, Sham PC, Hoda F, Arranz MJ, Li T, et al. Catechol-O-methyltransferase polymorphisms and schizophrenia: A transmission disequilibrium study in multiply affected families. Psychiatr Genet. 1997;7:97–101
  18. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC), I: Effects on dorsal horn convergent neurones in the rat. Pain. 1979;6:283–304
  19. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNICP), II: Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain. 1979;6:305–327
  20. Marchand S, Arsenault P. Spatial summation for pain perception: Interaction of inhibitory and excitatory mechanisms. Pain. 2002;95:201–206
  21. Martikainen IK, Hagelberg N, Mansikka H, Hietala J, Nagren K, Scheinin H, et al. Association of striatal D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia. Neurosci Lett. 2005;376:149–153
  22. Meeus M, Nijs J. Central sensitization: A biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol. 2007;26:465–473
  23. Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66:355–474
  24. Morgan MJ, Franklin KBJ. 6-Hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test. Brain Res. 1990;519:144–149
  25. Pertovaara A, Martikainen IK, Hagelberg N, Mansikka H, Nagren K, Hietala J, et al. Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain. Eur J Neurosci. 2004;20:1587–1592
  26. Piccardi MP, Severino G, Bocchetta A, Palmas MA, Ruiu S, Del Zompo M. No evidence of association between dopamine D3 receptor gene and bipolar affective disorder. Am J Med Genet. 1997;74:137–139
  27. Scott DJ, Heitzeg MM, Koeppe RA, Stohler CS, Zubieta JK. Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine. J Neurosci. 2006;26:10789–10795
  28. Tander B, Gunes S, Boke O, Alayli G, Kara N, Bagci H, et al. Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: A study on fibromyalgia susceptibility. Rheumatol Int. 2008;28:685–691
  29. Vargas-Alarcon G, Fragoso JM, Cruz-Robles D, Vargas A, Vargas A, Lao-Villadoniga JI, et al. Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther. 2007;9:R110
  30. Willer JC, Debroucker T, Le Bars D. Encoding of nociceptive thermal stimuli by diffuse noxious inhibitory controls in humans. J Neurophysiol. 1989;62:1028–1038
  31. Wolfe F, Snilders AMJ, Yunus MB. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–172
  32. Wood PB, Patterson JC, Sunderland JJ, Tainter KH, Glabus MF, Lilien DL. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study. J Pain. 2007;8:51–58
  33. Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA, et al. Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci. 2007;25:3576–3582
  34. Wood PB. A reconsideration of the relevance of systemic low-dose ketamine to the pathophysiology of fibromyalgia. J Pain. 2006;7:611–614
  35. Wood PB. Mesolimbic dopaminergic mechanisms and pain control. Pain. 2006;120:230–234
  36. Zinkstok J, van Amelsvoort T, de Haan L, Baas F, Linszen D. The Catechol-O-Methyltransferase Gene and Schizophrenia. In:  Lang MV editors. Trends in Schizophrenia Research. New York: Nova Biomedical Books; 2005;p. 45–78
  37. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, et al. COMT Val158Met genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science. 2003;299:1240–1243

 Drs Potvin and Larouche contributed equally to this work.

 Dr Marchand is holder of the Pain Chair from the University of Sherbrooke and UQAT and a supported member of the Centre de recherche clinique Étienne-Le Bel du Centre Hospitalier Universitaire de Sherbrooke (Fonds de Recherche en Santé du Québec). Dr Potvin is holder of a postdoctoral scholarship from the Canadian Institute of Health Research (CIHR). Dr Marchand holds grants from the CIHR. Dr Grignon is a member of the Centre de Recherches Cliniques Etienne-Le Bel and of the Centre des Neurosciences de Sherbrooke. Genotyping studies were funded in part by an unrestricted grant from Novartis Canada to the Department of Psychiatry, Sherbrooke University.

PII: S1526-5900(09)00471-4

doi: 10.1016/j.jpain.2009.03.013

The Journal of Pain
Volume 10, Issue 9 , Pages 969-975 , September 2009

Article Tools

* Image Usage & Resolution